Skip to content

Released May 7, 2025, after the close

10-Q filed May 9, 2025, 39 days after period end · 0001636422-25-000069

Q1 2025 · 10-Q
Revenue$79.41M+6.3% vs Q1 2024−0.2% vs Q4 2024
Net Income-$23.74MN/M vs Q1 2024N/M vs Q4 2024
EPS Diluted-$0.35N/M vs Q1 2024no prior Q4 2024 on file
Operating Income-$20,171,000N/M
Operating Cash Flow$280,000−97.3%
Free Cash Flowderived-$390,000N/M
Margins · derived
Operating margin-25.4%+5.1 pt vs Q1 2024
Net margin-29.9%−2.3 pt vs Q1 2024

What the release said

The release

Same quarter

MetricQ1 2025Q1 2024Q1 2023Q1 2022
Revenue$79.41M$74.72M$73.87M$68.09M
Net Income-$23.74M-$20.59M-$33.19M-$22.46M
EPS Diluted-$0.35-$0.35-$0.60-$0.54

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR